Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect

The combination of MEK inhibitor (cobimetinib, trametinib) and BRAF inhibitor (vemurafenib, dabrafenib) is now the first-line treatment in patients with BRAF V600-mutated metastatic melanoma. This association reduces cutaneous adverse events induced by BRAF inhibitors alone, including photosensitivi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Dermatol
Main Authors: Negulescu, Miruna, Deilhes, Florian, Sibaud, Vincent, Tournier, Emilie, Lamant, Laurence, Boulinguez, Serge, Meyer, Nicolas
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2017
Assuntos:
Single Case
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5465775/
https://ncbi.nlm.nih.gov/pubmed/28611627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000461571
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados